Harmony Biosciences Holdings (HRMY) Interest & Investment Income (2019 - 2026)
Harmony Biosciences Holdings recorded quarterly Interest & Investment Income of $5.8 million in Q1 2026, down 1.66% quarter-over-quarter from $5.9 million in Q4 2025, and up 14.14% year-over-year from $5.0 million in Q1 2025.
Harmony Biosciences Holdings' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $5.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 14.14% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $22.6 million (up 18.16% YoY), while the FY2025 annual figure was $21.9 million, up 18.24% from the prior year.
- Interest & Investment Income came in at $5.8 million for Q1 2026 at Harmony Biosciences Holdings, down from $5.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $15.2 million in Q4 2022 to a low of -$4.2 million in Q1 2022.
- A 5-year average of $3.8 million and a median of $4.5 million in 2024 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 202.91% in 2023 and fell as far as 73.07% in 2023.
- Harmony Biosciences Holdings' Interest & Investment Income stood at $15.2 million in 2022, then sank by 73.07% to $4.1 million in 2023, then advanced by 9.3% to $4.5 million in 2024, then surged by 30.76% to $5.9 million in 2025, then decreased by 1.66% to $5.8 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $5.8 million, $5.9 million, and $5.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | 5.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.76 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 4.48 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 4.71 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | 4.11 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 15.21 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | -3.93 Mn |
| Mar 31, 2022 | -4.17 Mn |
| Dec 31, 2021 | 20.01 Mn |
| Sep 30, 2021 | -5.43 Mn |
| Jun 30, 2021 | -7.23 Mn |
| Mar 31, 2021 | -7.13 Mn |
| Dec 31, 2020 | -7.97 Mn |
| Sep 30, 2020 | -6.95 Mn |
| Jun 30, 2020 | -6.94 Mn |
| Mar 31, 2020 | -6.37 Mn |
| Dec 31, 2019 | -2.75 Mn |
| Sep 30, 2019 | -2.10 Mn |